---
figid: PMC7519203__OMCL2020-6401341.008
figlink: pmc/articles/PMC7519203/figure/fig8/
number: Figure 8
caption: 'Proinflammatory signaling that occurs during viral infection and mechanisms
  through which R-BHB inhibits this signaling. (a) The ACE system. (b) The mechanism
  by which R-BHB inhibits the NLRP3 inflammasome is unknown. Four possible mechanisms
  are shown. (c) The hexosamine biosynthesis pathway is required to initiate an effective
  antiviral innate immune response, but its increased activity can also stimulate
  a cytokine storm. Abbreviations: 6PGDL: 6-phosphonoglocono-D-lactone; 6PG: 6-phosphogluconate;
  ACE2: angiotensin-converting enzyme 2; ACE: angiotensin-converting enzyme; ANG (1-9):
  angiotensin (1-9); ANG (1-7): angiotensin (1-7), a vasodilator; ANG II: angiotensin
  II, a vasoconstrictor; ANG III: angiotensin III, a metabolite of ANG II; BRCC3:
  Lys-63-specific deubiquitinase BRCC36; CARD: caspase recruitment domain; CLIC: chloride
  intracellular channel protein; F1,6BP: fructose 1,6-bisphosphate; F6P: fructose
  6-phosphate; FADD: fas-associated protein with death domain; GlcNAc: G,N-acetylglucosamine;
  G3P: glyceraldehyde 3-phosphate; G6P: glucose 6-phosphate; GlcN-6P: glucosamine-6-phosphate;
  GlcNAc-6P: N-acetyl glucosamine-6-phosphate; GlcNAc-1p: N-acetyl glucosamine-1-phosphate;
  HBP: hexosamine biosynthesis pathway; IKKε: IκB kinase ε; IL-1R: interleukin-1 receptor;
  IRAK-1 and IRAK-4: interleukin-1 receptor kinases 1 and 4; IRF3 and IRF5: IFN-regulatory
  factors 3 and 5; JNK1: c-Jun N-terminal protein kinase 1; K63-Ub: K63-linked polyubiquitin
  binding; MasR: Mas receptor; MAVS: mitochondrial antiviral signaling protein; MDA5:
  melanoma differentiation-associated gene 5; MyD88: myeloid differentiation primary
  response 88; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells;
  NLRP3: NOD-, LRR-, and pyrin domain-containing protein 3; NOD1 and NOD2: nucleotide-binding
  oligomerization domain-containing proteins 1 and 2; OGT: O-linked N-acetylglucosamine
  (GlcNAc) transferase; P2X7: P2X purinoceptor 7; PDPK: phosphoinositide-dependent
  kinase-1; PPP: pentose phosphate pathway; PTMs: posttranslational modifications;
  R5P: ribose 5-phosphate; RIG-1: retinoic acid-inducible gene I; S7P: sedoheptulose
  7-phosphate; SERCA: sarcoplasmic/endoplasmic reticulum Ca2+-ATPase; STAT3: signal
  transducer and activator of transcription 3; TBK-1: TANK-binding kinase 1; TLR:
  toll-like receptor; TNFR: tumor necrosis factor receptor; TRAF6: tumor necrosis
  factor receptor- (TNFR-) associated factor 6; TRIF: TIR domain-containing adapter-inducing
  interferon β; TRX: thioredoxin; TXNIP: thioredoxin-interacting protein; UDP-GlcNAc:
  uridine diphosphate N-acetylglucosamine.'
pmcid: PMC7519203
papertitle: 'COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to
  Blunt the Cytokine Storm.'
reftext: Patrick C. Bradshaw, et al. Oxid Med Cell Longev. 2020;2020:6401341.
pmc_ranked_result_index: '76194'
pathway_score: 0.9078863
filename: OMCL2020-6401341.008.jpg
figtitle: Proinflammatory signaling that occurs during viral infection and mechanisms
  through which R-BHB inhibits this signaling
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7519203__OMCL2020-6401341.008.html
  '@type': Dataset
  description: 'Proinflammatory signaling that occurs during viral infection and mechanisms
    through which R-BHB inhibits this signaling. (a) The ACE system. (b) The mechanism
    by which R-BHB inhibits the NLRP3 inflammasome is unknown. Four possible mechanisms
    are shown. (c) The hexosamine biosynthesis pathway is required to initiate an
    effective antiviral innate immune response, but its increased activity can also
    stimulate a cytokine storm. Abbreviations: 6PGDL: 6-phosphonoglocono-D-lactone;
    6PG: 6-phosphogluconate; ACE2: angiotensin-converting enzyme 2; ACE: angiotensin-converting
    enzyme; ANG (1-9): angiotensin (1-9); ANG (1-7): angiotensin (1-7), a vasodilator;
    ANG II: angiotensin II, a vasoconstrictor; ANG III: angiotensin III, a metabolite
    of ANG II; BRCC3: Lys-63-specific deubiquitinase BRCC36; CARD: caspase recruitment
    domain; CLIC: chloride intracellular channel protein; F1,6BP: fructose 1,6-bisphosphate;
    F6P: fructose 6-phosphate; FADD: fas-associated protein with death domain; GlcNAc:
    G,N-acetylglucosamine; G3P: glyceraldehyde 3-phosphate; G6P: glucose 6-phosphate;
    GlcN-6P: glucosamine-6-phosphate; GlcNAc-6P: N-acetyl glucosamine-6-phosphate;
    GlcNAc-1p: N-acetyl glucosamine-1-phosphate; HBP: hexosamine biosynthesis pathway;
    IKKε: IκB kinase ε; IL-1R: interleukin-1 receptor; IRAK-1 and IRAK-4: interleukin-1
    receptor kinases 1 and 4; IRF3 and IRF5: IFN-regulatory factors 3 and 5; JNK1:
    c-Jun N-terminal protein kinase 1; K63-Ub: K63-linked polyubiquitin binding; MasR:
    Mas receptor; MAVS: mitochondrial antiviral signaling protein; MDA5: melanoma
    differentiation-associated gene 5; MyD88: myeloid differentiation primary response
    88; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; NLRP3:
    NOD-, LRR-, and pyrin domain-containing protein 3; NOD1 and NOD2: nucleotide-binding
    oligomerization domain-containing proteins 1 and 2; OGT: O-linked N-acetylglucosamine
    (GlcNAc) transferase; P2X7: P2X purinoceptor 7; PDPK: phosphoinositide-dependent
    kinase-1; PPP: pentose phosphate pathway; PTMs: posttranslational modifications;
    R5P: ribose 5-phosphate; RIG-1: retinoic acid-inducible gene I; S7P: sedoheptulose
    7-phosphate; SERCA: sarcoplasmic/endoplasmic reticulum Ca2+-ATPase; STAT3: signal
    transducer and activator of transcription 3; TBK-1: TANK-binding kinase 1; TLR:
    toll-like receptor; TNFR: tumor necrosis factor receptor; TRAF6: tumor necrosis
    factor receptor- (TNFR-) associated factor 6; TRIF: TIR domain-containing adapter-inducing
    interferon β; TRX: thioredoxin; TXNIP: thioredoxin-interacting protein; UDP-GlcNAc:
    uridine diphosphate N-acetylglucosamine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TBK1
  - MYD88
  - IRAK4
  - IRAK1
  - FADD
  - MAVS
  - TXN
  - TXNIP
  - PTMS
  - NLRP3
  - WDTC1
  - IL18
  - SARS
  - ATP2A1
  - ATP2A2
  - ATP2A3
  - TLR8
  - TLR7
  - TRAF6
  - OGT
  - STAT3
  - CHUK
  - IKBKG
  - IKBKB
  - IRF3
  - OPN1LW
  - BHB
  - Na
  - NADPH
  - ATP
  - NADP
  - ADP
  - 2H Ca
  - Ca
  - glucose
  - Glucose
  - Pyruvate
  - Lactate
  - GlcNAc
  - UDP
  - O
  - SARS COV-2
genes:
- word: Na-K
  symbol: NAK
  source: hgnc_alias_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: IRAK-4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IRAK-1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: MAVS
  symbol: MAVS
  source: hgnc_symbol
  hgnc_symbol: MAVS
  entrez: '57506'
- word: TRX
  symbol: TRX
  source: hgnc_alias_symbol
  hgnc_symbol: TXN
  entrez: '7295'
- word: TXNIP
  symbol: TXNIP
  source: hgnc_symbol
  hgnc_symbol: TXNIP
  entrez: '10628'
- word: PTMS,
  symbol: PTMS
  source: hgnc_symbol
  hgnc_symbol: PTMS
  entrez: '5763'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: TXNIP
  symbol: TXNIP
  source: hgnc_symbol
  hgnc_symbol: TXNIP
  entrez: '10628'
- word: NIRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: SARS
  symbol: SARS
  source: hgnc_symbol
  hgnc_symbol: SARS
  entrez: '6301'
- word: Pro-IL-16,NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: SERCA
  symbol: SERCA
  source: bioentities_symbol
  hgnc_symbol: ATP2A1
  entrez: '487'
- word: SERCA
  symbol: SERCA
  source: bioentities_symbol
  hgnc_symbol: ATP2A2
  entrez: '488'
- word: SERCA
  symbol: SERCA
  source: bioentities_symbol
  hgnc_symbol: ATP2A3
  entrez: '489'
- word: TLR7/8
  symbol: TLR8
  source: hgnc_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR7/8
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: OGT
  symbol: OGT
  source: hgnc_symbol
  hgnc_symbol: OGT
  entrez: '8473'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: OGT
  symbol: OGT
  source: hgnc_symbol
  hgnc_symbol: OGT
  entrez: '8473'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: TBK-1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: СВР
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
chemicals:
- word: BHB
  source: MESH
  identifier: C045922
- word: Na
  source: MESH
  identifier: D012964
- word: NADPH
  source: MESH
  identifier: D009249
- word: ATP
  source: MESH
  identifier: D000255
- word: NADP
  source: MESH
  identifier: D009249
- word: ADP
  source: MESH
  identifier: D000244
- word: 2H Ca
  source: MESH
  identifier: D002118
- word: Ca
  source: MESH
  identifier: D002118
- word: glucose
  source: MESH
  identifier: D005947
- word: Glucose
  source: MESH
  identifier: D005947
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Lactate
  source: MESH
  identifier: D019344
- word: GlcNAc
  source: MESH
  identifier: C097320
- word: UDP
  source: MESH
  identifier: D014530
- word: O
  source: MESH
  identifier: D013481
diseases:
- word: SARS COV-2
  source: MESH
  identifier: D045169
---
